Keywords: India, Bayer, Nexavar, Cipla, Patent linkage,

Bayer’s patent linkage appeal to be heard by India’s Supreme Court

Article | 01 March 2010

Print This

German drug major Bayer seems to be making some progress in its patent fight in India, after the country’s ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in